EU indices up this morning | TA focus on ArcelorMittal


European stocks report | GlaxoSmithKline | William Hill | Commerzbank | ArcelorMittal...

Stocks (3)

Friday, European stocks closed mixed. The Stoxx Europe 600 Index edged down 0.10%, Germany's DAX 30 dropped 1.08%, France's CAC 40 slipped 0.69%, while the U.K.'s FTSE 100 added 0.34%.

52% of STOXX 600 constituents traded lower or unchanged Friday.
31% of the shares trade above their 20D MA vs 29% Thursday (below the 20D moving average).
50% of the shares trade above their 200D MA vs 50% Thursday (below the 20D moving average).

The Euro Stoxx 50 Volatility index eased 0.54pt to 27.81, a new 52w high.

3mths relative high: Pers. & House. Goods
3mths relative low: Telecom., Insurance, Banks, Energy

Europe Best 3 sectors
travel & leisure, media, utilities

Europe worst 3 sectors
automobiles & parts, energy, banks

The 10yr Bund yield was unchanged to -0.5% (below its 20D MA). The 2yr-10yr yield spread rose 2bps to -18bps (above its 20D MA).

GE 10:45: 12-Mth Bubill auction, exp.: -0.57%
FR 14:00: 12-Mth BTF auction, exp.: -0.58%
FR 14:00: 3-Mth BTF auction, exp.: -0.57%
FR 14:00: 6-Mth BTF auction, exp.: -0.58%

In Asian trading hours, EUR/USD edged up to 1.1635 and GBP/USD rebounded to 1.2769. USD/JPY retreated to 105.38.

Spot gold remained subdued at $1,860 an ounce.

William Hill, a bookmaker, and American resorts operator Caesars Entertainment confirmed that they are in advanced discussions concerning a possible 272p per share cash offer for William Hill, adding that "Caesars has finalised its due diligence and a further announcement will be made as and when appropriate".

GlaxoSmithKline, a pharmaceutical company, reported that the U.S. Food and Drug Administration has approved its Nucala "as the first and only biologic treatment for Hypereosinophilic Syndrome".

Aviva, an insurance group, was upgraded to "buy" from "hold" at Deutsche Bank.

Commerzbank, a banking group, announced the appointment of Manfred Knof, currently Head of Deutsche Bank's Private Bank Germany, as successor to Chairman Martin Zielke from January 1, 2021.

Daimler, an automobile group, may pick Joe Kaeser, currently a board member, to succeed chairman Manfred Bischoff next year, according to Bloomberg.

Air France-KLM's, an airline group, French arm Air France said it will operate 50% of its flight schedule planned for November and December 2020, due to the current applicable travel restrictions.

Veolia, a resource management company, confirmed that it will submit its improved offer for Engie's stake in Suez by September 30.

ArcelorMittal, a steel producer, announced that it has agreed to sell its ArcelorMittal USA to Cleveland-Cliffs for an aggregate equity value consideration of 1.4 billion dollars, with upfront cash of 505 million dollars and the remainder in the form of equity.
From a weekly point of view, the share is capped by a declining trend line drawn since May 2018. Moreover, the 52 exponential moving average plays a resistance role, while the RSI has struck against the resistance level at 56.6%. Below the overlap area at 11.7E look for the horizontal support of May at 7.9E and 6E in extension.

Source: TradingView, GAIN Capital

Galapagos and Gilead Sciences, the two pharmaceutical groups, announced that the European Commission has granted marketing authorization for Jyseleca (filgotinib) for the treatment of adults with moderate to severe active rheumathoid arthritis.

Sonova, a hearing technology company, raised its 1H revenue guidance to 79% of prior year levels from 65% - 75% previously and sees an adjusted EBITA decline of 30%, both at constant exchange rates. For the full-year, the company expects revenue to reach 92% - 94% of prior year levels and an adjusted EBITA at around prior year level, both at constant exchange rates.

Chr Hansen, a bioscience company, announced that it has agreed to sell its Natural Colors Division to investment firm EQT for 800 million euros.

More from Equities

From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.